Key Market Indicators
Sales of Finnish digestive system disorder medicines are expected to reach $390.2 million by 2026. This number is up from $365.1 million in 2021, growing at an annual rate of 1.1%. Since 1994, the Finnish market has seen a 1.8% year-on-year growth. In 2021, Finland ranked 19th in this market, with Norway overtaking them with $365.1 million. Japan, South Korea and Canada were the second, third and fourth biggest markets, respectively.
